Enhertu (Trastuzumab deruxtecan Vials) 100mg

Enhertu (trastuzumab deruxtecan) is an antibody-drug conjugate used in oncology. This 100mg vial formulation supports targeted therapy for certain cancers. Store between 2-8°C to maintain stability. Consult healthcare providers for personalized treatment plans.

Strength

100mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Daiichi Sankyo Europe GmbH

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trastuzumab deruxtecan is primarily used to treat specific types of breast cancer and other HER2-positive malignancies. It may be prescribed when standard therapies are no longer effective. This medication targets cancer cells with HER2 receptors, helping to slow disease progression. Patients should discuss eligibility with their oncologist.

Side Effects

This medication works by delivering chemotherapy directly to cancer cells while sparing healthy tissue. Common effects include temporary reductions in cancer-related symptoms such as pain or fatigue. Some patients may experience mild gastrointestinal discomfort during treatment. Individual responses vary based on medical history.

Precautions & Warnings

Store vials refrigerated between 2-8°C and protect from light. Avoid freezing or shaking the vial. Handle with care to prevent contamination. Keep out of reach of children and pets. Report any signs of allergic reactions to a healthcare professional immediately.

Avoid Interactions

Certain medications may affect how trastuzumab deruxtecan works, including strong CYP3A inhibitors or inducers. Blood thinners and other cancer therapies may require dose adjustments. Alcohol and herbal supplements could also interact—discuss all current medications with your doctor. Always inform healthcare providers before starting new treatments.

References

Frequently Asked Questions

Enhertu is used to treat certain HER2-positive cancers, including breast cancer.

Store vials refrigerated between 2-8°C and protect from light.

Consult your doctor before combining with other drugs, as interactions are possible.

Some patients report mild gastrointestinal discomfort or fatigue during treatment.

No, Enhertu is a brand-name medication containing trastuzumab deruxtecan.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.